INSIGHTS ON DRUG DEVELOPMENT
-
Improved Cell Viability For Multi-Day Cell-Based Assays
Ensure consistent cell health and assay reliability with controlled temperature and gas conditions. Discover how microplate readers with gas mixers enhance cell viability in live cell-based assays.
-
Using AI-Analysis And High-Content Screening To Improve Data Capturing
Discover an advanced 3D imaging for drug discovery that features high-throughput, high-quality images, modular hardware, and intuitive software for precise, rapid analysis.
-
An All-In-One Solution For Residual DNA Quantitation
Explore an all-in-one solution for residual DNA quantitation with a 3D lab tour with virtual demos, videos, and interactive instrument guides to experience the full workflow.
-
A CDMO Is The Nexus Between Green Chemistry And Commercialization
Modern R&D transforms sustainability from an optional add-on into a strategic optimization tool, enhancing cost-efficiency, speed to market, and process intensification for drug developers.
-
High Potency APIs And The Evolving Demands Of Drug Development4/13/2026
See how higher API activity is changing expectations around containment, scalability, and cross‑functional alignment — and why early decisions now have a greater impact on long‑term success.
-
Accelerate FDA Approval With Fast Track Designation7/3/2025
Learn how Fast Track Designation streamlines the FDA review process and offers faster approval for serious diseases or life-threatening conditions.
-
EMA Support For Rare Disease Therapies6/10/2025
Review how the EMA supports rare disease drug development through regulatory and financial incentives for therapies that meet strict eligibility and ongoing compliance criteria.
-
Redefining OSD Development Through Foresight And Innovation2/12/2026
From early formulation challenges to scale-up and commercial readiness, proactive planning and integrated capabilities help teams anticipate risks, accelerate decision-making, and maintain momentum across development.
-
Three Keys To E&L Success: Study Design, Partner Selection, And Timing7/16/2026
Successful E&L planning starts before testing begins. Aligning study design, partner expertise, and timing helps teams focus on the right risks, avoid surprises, and support stronger development.
DRUG DEVELOPMENT SOLUTIONS
-
Support high-yield viral vector production with media designed for transfection efficiency, scalability, and reduced aggregation in HEK293 cells, ideal for AAV and LV workflows.
-
As a dedicated center of excellence in this product family, we offer a high degree of versatility and tailored solutions to meet the specific needs of each client.
-
Discover a new system that offers high-speed camera options and versatile customization to enhance calcium oscillation analysis and streamline workflows for efficient drug discovery.
-
Digital microscopy with automated brightfield, fluorescence, and Digital Confocal imaging
The ImageXpress® Pico Automated Cell Imaging System is more than a digital microscope, combining high-resolution imaging with powerful analysis. Whether running fluorescence imaging or brightfield assays, the automated imager features a comprehensive portfolio of preconfigured protocols for cell-based assays to shorten the learning curve, so you can start running experiments quickly.
-
Model MS fragmentation pathways and align predictions with experimental data to assign fragment ions faster. Streamline spectral interpretation and confirm compound identities with greater confidence.